BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 17, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 14, 1998
View Archived Issues
IL-15 potentiates antitumor activity of 5-FU/leucovorin in colorectal cancer
Read More
Neuroprotective effects of YM-39558, a potential treatment for stroke
Read More
Sabcomeline treatment results in cognitive enhancement in nonhuman primates
Read More
Prevention of diabetes with nicotinamide -- the DENIS multicenter study
Read More
Idoxifene: another SERM with clinical potential in postmenopausal disorders
Read More
Interneuron initiates phase III CerAxon study and licenses citicoline patent rights to Ferrer
Read More
New evidence supports the efficacy of PKC inhibition in diabetic neuropathy
Read More
Vitamin D analogue EB-1089 acts via effects on IGF-I
Read More
EM-800, a more potent antiestrogen than raloxifene in preclinical studies
Read More
Alexion initiates C5 inhibitor phase I/II clinical trial for rheumatoid arthritis
Read More
Anergen initiates clinical trials with AnergiX
Read More
Vivus seeks partner to promote Muse in the U.S.
Read More
Preclinical overview of nepicastat cardiovascular effects
Read More
NPY Y1 receptor agonists from Ortho with anxiolytic activity
Read More
Hydroxamic acid-based MMP inhibitors described by P&U
Read More
Vertex describes new protease inhibitors as therapeutics for HCV
Read More
Merck & Co.'s new tachykinin antagonists
Read More
SS Pharm. presents novel ACAT inhibitors for arteriosclerosis
Read More
Advisory committee recommends approval of Pletal
Read More
Zyrtec registered in Japan, launch scheduled for September
Read More
Phase III trial of new foam formulation of clobetasol initiated
Read More
Spotlight on estrone sulfatase inhibitors for treatment of breast cancer
Read More
Potent, broad-spectrum antitumor arylsulfonylimidazolidinone selected by Dong Wha
Read More
Sanwa Kagaku selects optically active candidate gastric prokinetic agent
Read More
Panels report guidelines for HIV and CMV therapy
Read More
